David L. Barker's most recent trade in Bionano Genomics Inc was a trade of 2,775 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 2,775 | 2,775 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| Singular Genomics Systems Inc | David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 60,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Singular Genomics Systems Inc | David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 07 Jul 2022 | 60,000 | 60,000 | - | 0.6 | 37,800 | Common Stock |
| Bionano Genomics Inc | David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 44,470 | 0 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | David L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 07 Jul 2022 | 44,470 | 58,364 (0%) | 0% | 0.5 | 22,680 | Common Stock |
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 164,422 | 164,422 | - | - | Stock Option (right to buy) | |
| Singular Genomics Systems Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | David L. Barker | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 16 May 2022 | 10,000 | 13,894 (0%) | 0% | 1.6 | 16,000 | Common Stock |
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 40,751 | 40,751 | - | - | Stock Option (right to buy) | |
| Bionano Genomics Inc | David L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 7,528 | 7,528 | - | - | Stock Option (right to buy) |